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ABSTRACT
Rad51C is a central component of two complexes
formed by five Rad51 paralogs in vertebrates. These
complexes are involved in repairing DNA double-
strand breaks through homologous recombination.
Despite accumulating evidence suggesting that the
paralogs may prevent aneuploidy by controlling
centrosome integrity, Rad51C’s role in maintaining
chromosome stability remains unclear. Here we
demonstrate that Rad51C deficiency leads to both
centrosome aberrations in an ATR-Chk1-dependent
manner and increased aneuploidy in human cells.
While it was reported that Rad51C deficiency did
not cause centrosome aberrations in interphase
in hamster cells, such aberrations were observed
in interphase in HCT116 cells with Rad51C dysfunc-
tion. Caffeine treatment and down-regulation of
ATR, but not that of ATM, reduced the frequency
of centrosome aberrations in the mutant cells.
Silencing of Rad51C by RNA interference in
HT1080 cells resulted in similar aberrations.
Treatment with a Chk1 inhibitor and silencing of
Chk1 also reduced the frequency in HCT116
mutants. Accumulation of Chk1 at the centrosome
and nuclear foci of cH2AX were increased in the
mutants. Moreover, the mutant cells had a higher
frequency of aneuploidy. These findings indicate
that the ATR-Chk1 pathway plays a role in increased
centrosome aberrations induced by Rad51C
dysfunction.
INTRODUCTION
Homologous recombination, along with nonhomologous
end-joining, plays a major role in the repair of DNA
double-stranded breaks (DSBs) (1). Rad51 is a key
player in homologous recombination by exerting homol-
ogous pairing and strand exchange activities. Rad51 para-
logs are assumed to be involved in the early stages of
homologous recombination by assisting Rad51 function
(2). Five members of the Rad51 paralog family constitute
two protein complexes: Rad51B-Rad51C-Rad51D-
XRCC2 (BCDX2) and Rad51C-XRCC3 (3,4). Thus,
Rad51C is a central component among ﬁve members
in vertebrates.
The centrosome serves as the microtubule-organizing
center, ensuring correct chromosome segregation to pre-
vent aneuploidy (5). Accumulating evidence suggests
that centrosome dysfunction, typically represented by
abnormal numbers of centrosomes, is involved in human
diseases, particularly in cancers (6). More than 100 pro-
teins have been reported to be localized in the centrosome
(7). Deletion of these proteins often leads to centrosome
aberrations.
Mutations of XRCC2, XRCC3, Rad51B and Rad51D
were shown to increase centrosome fragmentation and
aneuploidy (8–10). Despite these observations, the role
of Rad51C in the maintenance of centrosome integrity
and chromosome stability remains unclear. Initially,
Rad51C-deﬁcient Chinese hamster ovary (CHO) cells,
CL-V4B, were shown to exhibit no increase in centro-
some aberrations (11). A recent study, however, demon-
strated that centrosome numbers were increased only in
mitosis and not in interphase in CL-V4B cells (12).
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are assumed to generate aneuploidy, no studies using
mammalian cells have demonstrated that Rad51C deﬁ-
ciency leads to increased aneuploidy.
The mechanisms underlying centrosome aberrations
observed in cells with a defect in homologous recombi-
nation are controversial. In chicken DT40 cells with a
conditional mutation of Rad51, the ATM-dependent
checkpoint pathway was proposed to be responsible for
centrosome ampliﬁcation at the G2 phase (13). However,
the results of a study using CHO cells with the dominant-
negative Rad51 protein argued against this result (14).
The hereditary breast cancer susceptibility protein
BRCA1 is also involved in homologous recombination.
Recent evidence suggests that HMMR, encoding the
hyaluronan-mediated motility receptor, is a substrate of
BRCA1-BARD1 E3 ubiquitin ligase activity and plays a
role in centrosomal function (15).
Supernumerary centrosomes induced by ionizing radia-
tion were shown to be caused by the Chk1-mediated path-
way, indicating that the DNA damage response signal is
involved in centrosome ampliﬁcation (16). Treatment with
caﬀeine, an inhibitor of ATM and ATR kinases, reduced
centrosome ampliﬁcation induced by ionizing radiation,
suggesting that either or both kinases may be involved
in centrosome ampliﬁcation. However, caﬀeine treatment
in ATM- or ATR-deﬁcient cells also reduced centrosome
ampliﬁcation. Thus, the roles of ATM and ATR in pro-
moting centrosome ampliﬁcation induced by ionizing
radiation appear to be complementary.
To investigate Rad51C’s role in the maintenance of
chromosome stability, we knocked out the gene in the
human colon cancer cell line HCT116. We also silenced
the gene by RNA interference in the human ﬁbrosarcoma
cell line HT1080. Supernumerary centrosomes in these
cells with Rad51C dysfunction were increased at both
interphase and metaphase in an ATR-Chk1-dependent
manner. Consistent with this observation, aneuploidy
was increased in HCT116 cells with Rad51C dysfunction.
Our observations suggest that the ATR-Chk1 pathway
plays a role in increased centrosome aberrations induced
by Rad51C dysfunction in human cancer cells.
MATERIALS AND METHODS
Cell culture
HCT116 cells were cultured in McCoy’s 5A medium sup-
plemented with 10% fetal bovine serum (FBS). HT1080
cells were cultured in the minimum essential medium
Eagle (MEM) supplemented with 10% FBS. These cells
were obtained from the American Type Culture
Collection. 2-Morpholin-4-yl-6-thianthren-1-yl-pyran-
4-one (KU55933) and 7-hydroxystaurosporine (UCN-01)
were purchased from Merck Calbiochem.
Generation of Rad51C mutant cells
The 8-kb left arm and 1.5-kb right arm of the RAD51C
genomic fragments were isolated from the EMBL3 SP6/T7
human genomic library (Clontech) and inserted into
pBluescript SK for neomycin and blasticidin selection.
The shorter genomic fragment was isolated from the geno-
mic DNA of HCT116 by PCR ampliﬁcation for puromy-
cin selection. The 2.4-kb left arm was ampliﬁed using
primers 50-TTTGGCTGCTCCGGGGTTA-30 and 50-CA
GAGTTTCTAAGGCTTCTGC-30. The 1.5-kb right arm
was ampliﬁed using primers 50-CTCGAGTGGAGTGCC
CTTAAT-30 and 50-CTCGAGTCAACAGAAAGATGA
C-30. Promoterless neomycin-, blasticidin- and puromy-
cin-resistant genes were inserted into the Dra I site in
exon 2. Gene targeting in HCT116 was carried out as
previously described (17).
Complementation experiments
The RAD51C cDNA was ampliﬁed from normal human
cDNA using primers 50-TTTGGCTGCTCCGGGGTTA-
30 and 50-CATTCATGCCATAGTGTG-30, and cloned
into pCR2.1 (Invitrogen) by the TA cloning method.
After the sequence was conﬁrmed, the cDNA was inserted
into an expression vector under the control of the MSV
enhancer and the MMTV promoter. The generation of the
XRCC3 expression vector has been described earlier (18).
Sensitivity to DNA-damaging agents
After 1 10
3cells were cultured in a 60mm dish for 24h,
they were exposed to mitomycin C (MMC) (Kyowa
Hakko Kogyo) for 10min, hydroxyurea (HU) (Sigma-
Aldrich) for 24h or g-ray irradiation. They were further
cultured for 9 days, and the colonies were counted.
Sister chromatid exchange (SCE) and gene targeting
frequency
SCEs were analyzed essentially as previously described
(17). Cells were cultured in 16mM 5-bromodeoxyuridine
(BrdU) for 36h (wild type), 42h (RAD51C
+/ / / )o r4 1h
(RAD51C
+/ / /  + cDNA), and pulsed with 0.1mg/ml
colcemid for the last 1h. To examine the eﬀect of
MMC, cells were incubated in the presence of 0.8mg/ml
MMC for 8h before harvest. Harvested cells were treated
with 75mM KCl:1% sodium citrate (4:1) for 20min and
ﬁxed with methanol:acetic acid (3:1). Cells were ﬁxed on
slides and incubated with 12.8mg/ml Hoechst 33258 for
20min. The slides were irradiated with ultraviolet for 1h
at 608C and stained with Giemsa solution. Gene targeting
frequencies at the RAD54B locus were examined as pre-
viously described (17).
Antibodies
Anti-ATM (5C2), ATR (N-19), Chk1 (G-4 and DCS-310)
and Cdk2 (M2) antibodies were from Santa Cruz
Biotechnology. Anti-g-tubulin (T3559 and T6557) and
b-actin (A1978) antibodies were from Sigma-Aldrich.
The anti-XRCC3 antibody (NB100-165) was from
Novus Biologicals. Anti-phospho-H2AX Ser 139
(07-164) and Chk2 (05-649) antibodies were from Upstate
Biotechnology. The anti-Chk2 antibody (DCS-273) was
from Medical & Biological Laboratories. The anti-
Rad51B antibody was obtained from rabbits immunized
with the recombinant Rad51B protein (19). The anti-
Rad51C antibody (ab3669) was from Abcam.
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Cells grown on coverslips were ﬁxed for 10min in 4%
paraformaldehyde. Then, they were permeabilized with
0.5% Triton X-100 and 0.1% SDS/PBS for 5min. Cells
were blocked with 10% horse serum at 48C for 30min
and incubated with primary antibodies at 378C for 1h
and with secondary antibodies for 30min. Finally, cells
were counterstained with 40,60-diamidino-2-phenylindole
(DAPI) and mounted. Slides were analyzed using
Olympus BX51-DP70, Carl Zeiss AxioImagerZ1/
Apotome and Nikon Confocal Laser Microscope
system A1.
Fluorescence in situ hybridization analysis
Chromosome-speciﬁc centromeric probes were obtained
from Vysis. DNA in cells was denatured in 70% forma-
mide/2  SSC at 738C for 5min. Hybridization was per-
formed in a CEP hybridization buﬀer (Vysis) at 428C for
1h. Slides were washed in 0.4  SSC/0.3% NP40 at 738C
for 2min and in 2  SSC/0.1% NP40 at room temperature
for 1min. Cellular DNA was stained with DAPI.
RNA interference
siCONTROL, Rad51C siGENOME set of 4, ATM
SMARTpool, ATR SMARTpool, Chk1 SMARTpool
and Chk2 SMARTpool small interference RNAs
(siRNAs) were purchased from Dharmacon. Cells were
transfected with 100nM siRNA and Dharmafect4
(Dharmacon) according to the manufacturer’s instruc-
tions. Cells were harvested at 72h post-transfection.
Cell-cycle analysis
Cells treated with siRNAs were harvested 72h after
transfection. EPICS XL (Beckman Coulter) was used for
cell-cycle analysis.
Kinase assay
Cells were dissolved into a lysis buﬀer (50mM Tris–HCl
pH 7.5, 150mM NaCl, 1% Nonidet P40, 10% glycerol
and 2mM EDTA) containing phosphatase inhibitors
(50nM cantharidin, 5nM microcystin and 25mM bromo-
tetramisole oxalate), 2mg/ml aprotinin and 0.5mM
PMSF for 15min on ice and lysed by sonication. After
centrifugation (12000rpm, 5min), the supernatant was
collected and precleared by incubation with normal IgG
for 1h and Protein G for 30min. Precleared lysate was
incubated with anti-Chk1 or anti-Chk2 antibody for 1h.
After incubation with Protein G, immunoprecipitates were
washed three times each with the lysis buﬀer and 25mM
Hepes. The washed precipitate was incubated in a kinase
reaction buﬀer (25mM Hepes pH 7.4, 15mM MgCl2,
80mM EGTA and 1mM DTT) with 0.1mM ATP,
3mCi[g-
32P]ATP and 10mg glutathione S-transferase
(GST)-Cdc25C (200–256) at 308C for 30min. The reaction
was stopped by the addition of the sample buﬀer and
subjected to SDS-PAGE. GST-Cdc25C (200–256) was
prepared as previously described (20).
RESULTS
Rad51C is involved in homologous recombination in
human cells
To investigate the role of Rad51C in human cells, the
gene was sequentially knocked out in HCT116 cells
(Figure 1A). In accordance with the ﬁnding that
RAD51C was frequently ampliﬁed in human cancer
cells, Southern blot analysis demonstrated that this cell
line harbors four alleles of the gene (Figure 1B) (21,22).
Two independent RAD51C
+/ / /  cell lines (#1 and #2)
were isolated. The levels of Rad51C expression in propor-
tion to targeting events were conﬁrmed by northern and
western blot analyses (Figure 1C and D). These cells were
used in function analysis as Rad51C mutant cells because
clear phenotypes indicating defective homologous recom-
bination in comparison with wild-type HCT116 cells were
observed. Complementation experiments were performed
using cells transfected with the exogenous Rad51C expres-
sion vector.
The mean of the frequency of SCE induced by MMC
per cell was 5.8 in the Rad51C mutant cells, a value that
was signiﬁcantly lower than 8.3, the mean value for wild-
type cells (Table 1). The SCE frequency increased to a
level comparable to that of the wild-type cells in cells
transfected with the Rad51C expression vector. Gene tar-
geting frequency was examined at the RAD54B locus,
because it was assumed that Rad54B is not functionally
related to Rad51C (17). The frequency in the Rad51C
mutant cells was 1.16%, which was signiﬁcantly lower
than 12.0%, the wild-type value. These results indicate
that Rad51C plays a role in homologous recombination,
a ﬁnding that is in accord with the observations in DT40,
CHO and HeLa cells (11,12,23,24).
Homologous recombination is required for the repair of
DSBs induced by DNA-damaging agents. The Rad51C
mutant cells were hypersensitive to ionizing radiation,
MMC and HU, which was complemented by the exoge-
nous expression of the gene, indicating that Rad51C plays
a role in DSB repair (Figure 2A–C). A defect in homolo-
gous recombination leads to an increase in chromosome
aberrations such as gaps and breaks. Giemsa staining
using a metaphase spread revealed that both chromosome-
and chromatid-type aberrations were increased in Rad51C
mutant cells, indicating that spontaneously arising DSBs
were not properly repaired (Table 2). These observations
suggest that Rad51C plays a role in the repair of DSB
through homologous recombination in human cells.
Rad51C dysfunction leads to increased centrosome
aberrations
Since Rad51C’s role in maintaining centrosome integrity
has been controversial (11,12), we examined centrosome
aberrations by immunostaining g-tubulin. Cells with more
than two centrosomes are observed more frequently in
two independent Rad51C mutant clones than in wild-
type cells (Figure 3A). The frequency of aberrant numbers
of interphase centrosomes (more than two) was 7.0% in
wild-type cells, whereas it was 28.0% (#1) and 30.3% (#2)
in the Rad51C mutant cells. RAD51C cDNA expression
Nucleic Acids Research, 2009,Vol.37, No. 12 3961in the mutant cells reduced the frequency to 16.3% (#2).
In mitosis, the frequency was 8.0% in wild-type cells, and
24.0% (#1) and 32.8% (#2) in the mutant cells. cDNA
expression in the mutant cells reduced the frequency to
21.5% (#2). Thus, unlike CHO cells with Rad51C muta-
tion, in which centrosome aberrations were observed only
at mitosis, the corresponding HCT116 cells demonstrated
centrosome aberrations at both interphase and mitosis.
To conﬁrm that a reduction in Rad51C levels leads to
centrosome aberrations in other human cells, we silenced
the gene in HT1080 cells by RNA interference. Western
blot analysis showed that Rad51C expression was not
altered in wild-type HT1080 cells and was reduced in
the cells transfected with Rad51C siRNA (Figure 3B).
The frequency of aberrant numbers of interphase centro-
somes was 4.6% in cells transfected with control siRNA,
whereas it was 9.1% in cells transfected with Rad51C
siRNA (Figure 3C). Thus, supernumerary centrosomes
were also increased in HT1080 cells with Rad51C
dysfunction.
Rad51C affects XRCC3 levels
Since Rad51C is a central component of protein com-
plexes formed by Rad51 paralogs, we investigated the
eﬀect of Rad51C dysfunction on the BCDX2 and
Rad51C-XRCC3 complexes by measuring levels of
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Figure 1. Generation of Rad51C mutant cells by gene targeting. (A) Strategy for gene targeting at the RAD51C locus. The targeting vectors,
restriction sites and the position of the probe used for the Southern blot analysis are shown. (B) Southern blot analysis of DNA digested with
Dra I. The size of the wild-type allele is 4.5kb. Insertion of drug-resistance genes changes the size to 5.1, 5.2 and 5.4kb. (C) Northern blot analysis of
polyadenylated RNAs hybridized with the full-length RAD51C cDNA. (D) Western blot analysis. The Rad51C protein was immunoprecipitated with
the rabbit polyclonal antibody and visualized by western blot analysis using the mouse monoclonal antibody.
Table 1. Sister chromatid exchanges and targeting frequency
Cell line SCEs per cell
a Targeted
integration
b
Spontaneous MMC-
induced
RAD54B-
hygro
RAD51C
+/+/+/+ 4.2 0.2 8.3 0.4 12.0% (13/108)
RAD51C
+/ / /  4.3 0.3 5.8 0.3
c 1.16% (1/86)
d
RAD51C
+/ / / +cDNA 5.0 0.2 8.2 0.4 N.D.
e
aNumber of SCEs per cells represents the mean SEM from 100
mitotic cells.
bThe frequency of targeted integration is shown as a percentage of the
targeted clones relative to the total number of hygromycin resistant
clones; the numbers of clones are given in parentheses.
cP<1.0 10
 4, based on Mann–Whitney U-tests, comparing wild-type
cells with RAD51C
+/ / /  cells.
dP=0.0025, based on Fisher’s exact tests, comparing wild-type cells
with RAD51C
+/ / /  cells.
eN.D., not determined.
3962 Nucleic Acids Research, 2009, Vol. 37,No. 12Rad51B and XRCC3. Western blot analysis revealed that
XRCC3 levels but not Rad51B levels were reduced in the
mutant cells (Figure 4A). The previous report that
XRCC3 was destabilized in Rad51C-deﬁcient human
cells is in accord with this ﬁnding (24). Next, we investi-
gated the eﬀect of reduced XRCC3 levels on centrosome
aberrations by expressing the XRCC3 cDNA in the
Rad51C mutant cells (Figure 4B and C). The frequency
of centrosome aberrations was not changed by stable
expression of XRCC3. Thus, centrosome aberrations
induced by Rad51C dysfunction are unlikely to result
from the destabilization of other Rad51 paralogs.
ATR is involved in promoting centrosome aberrations
We next examined the roles of ATM and ATR in centro-
some aberrations in Rad51C mutant cells by a treatment
with 2mM caﬀeine (Figure 5A). FACS analysis conﬁrmed
that caﬀeine treatment at this concentration did not aﬀect
cell-cycle progression (data not shown). This treatment
reduced the frequency of centrosome aberrations in the
B
A
100
S
u
r
v
i
v
a
l
 
(
%
) 10
1
0.1
024 6
IR (Gy)
WT
RAD51C+/-/-/-
RAD51C+/-/-/- + RAD51C
100
S
u
r
v
i
v
a
l
 
(
%
) 10
1
0.1
024 6
IR (Gy)
WT
RAD51C+/-/-/-
RAD51C+/-/-/- + RAD51C
WT
RAD51C+/-/-/-
RAD51C+/-/-/- + RAD51C
S
u
r
v
i
v
a
l
 
(
%
)
0.1
10
100
1
2.5 00 . 5 1 1 . 5 2
MMC (µg/ml)
WT
RAD51C+/-/-/-
RAD51C+/-/-/- + RAD51C
S
u
r
v
i
v
a
l
 
(
%
)
0.1
10
100
1
2.5 00 . 5 1 1 . 5 2
MMC (µg/ml)
WT
RAD51C+/-/-/-
RAD51C+/-/-/- + RAD51C
C
S
u
r
v
i
v
a
l
 
(
%
)
0.1
10
100
1
5 01 2 3 4
HU (mM)
WT
RAD51C+/-/-/-
RAD51C+/-/-/- + RAD51C
S
u
r
v
i
v
a
l
 
(
%
)
0.1
10
100
1
5 01 2 3 4
HU (mM)
WT
RAD51C+/-/-/-
RAD51C+/-/-/- + RAD51C
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Figure 3. Centrosome aberrations. (A) Centrosome aberrations in
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Table 2. Spontaneous chromosomal aberrations
Cell line Chromatid
type
Chromosome
type
Abnormal
cells
RAD51C
+/+/+/+ 23 3
RAD51C
+/ / /  12 7 17
RAD51C
+/ / / +cDNA 4 4 7
A total of 100 cells were scored for each cell line.
Nucleic Acids Research, 2009,Vol.37, No. 12 3963mutant from 29.0% to 15.8% (P<0.01, paired t-test),
indicating that ATM and/or ATR may be involved in
the generation of supernumerary centrosomes.
ATM’s eﬀect on the centrosomes was examined by
treatment with the ATM-speciﬁc inhibitor, KU55933
(Figure 5B). This treatment did not change the frequency
of supernumerary centrosomes, indicating that ATM was
not involved in the damage-dependent increase in super-
numerary centrosomes. Next, the eﬀects of ATM and
ATR on the centrosomes were examined by using RNA
interference to silence the genes. Western blot analysis
demonstrated that each protein was down-regulated by
RNA interference (Figure 5C). Treatment with ATM
siRNA slightly aﬀected the cell-cycle distribution of the
mutant cells, whereas treatment with ATR siRNA did not
aﬀect the distribution (Figure 5D). In accord with the
ﬁnding using the ATM inhibitor, the silencing of ATM
did not aﬀect the frequency, whereas the silencing of
ATR reduced the frequency from 23.3% to 14.7%
(P<0.01) (Figure 5E). This observation was also con-
ﬁrmed in HT1080 cells with Rad51C dysfunction. The
silencing of ATR reduced the frequency from 11.8% to
5.8% (P<0.01) (Figure 5F). These results indicate that
ATR but not ATM was involved in the generation of
supernumerary centrosomes. Because treatment with
ATR siRNA rescued centrosome aberrations related to
Rad51C depletion, ATR is likely to promote the genera-
tion of supernumerary centrosomes in the damage
response signaling pathway rather than in a pathway
directly associated with Rad51C.
Chk1 is involved in promoting centrosome aberrations
Since Chk1 is activated by ATR in response to DNA
damage, we examined the eﬀect of Chk1 inhibition
on centrosome aberrations by treatment with the Chk1
inhibitor UCN-01 at the concentration of 100nM in the
mutant cells. This treatment reduced the frequency of cen-
trosome aberrations from 33.0% to 19.7% (P<0.01)
(Figure 6A). Although UCN-01 was originally shown to
inhibit Chk1 rather than Chk2, a subsequent study using
GST-Cdc25C (200–256) as a substrate showed that the
drug inhibited the immunoprecipitated kinase activities
of Chk1 and Chk2 from wild-type HCT116 cells after
exposure to ionizing radiation (25). We examined inhibi-
tion of both kinases by the drug using GST-Cdc25C
(200–256) as a substrate in the mutant cells. In accord
with the previous result, UCN-01 inhibited both kinases
(Figure 6B). To determine which kinase is involved in the
generation of supernumerary centrosomes, we examined
the eﬀect of RNA interference of the kinases on the cen-
trosome aberrations (Figure 6C). Treatment with Chk1 or
Chk2 siRNA did not aﬀect the cell-cycle distribution of
the mutant cells (Figure 5D). Silencing of Chk1 by RNA
interference reduced the frequency from 30.0% to 17.3%,
whereas silencing of Chk2 did not aﬀect the frequency
(Figure 6D). These results indicate that the ATR-Chk1
pathway was involved in the generation of supernumerary
centrosomes.
Rad51C dysfunction promotes centrosomal
accumulation of Chk1
Chk1 was shown to localize to centrosomes in response
to the DNA damage induced by ultraviolet irradiation
or HU treatment (26). This observation suggested that
accumulation of Chk1 at centrosomes contributes to its
checkpoint functions. We examined centrosomal localiza-
tion of Chk1 by double immunoﬂuorescence of Chk1 and
pericentrin in HCT116 cells (Figure 6E and F). In accord
with the previous report, ultraviolet irradiation or hydro-
xyurea treatment promoted Chk1’s centrosomal localiza-
tion in HCT116 cells. The frequency of cells in which
Chk1 localizes to centrosomes was 12.0% in wild-type
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We next examined focus formation of phosphorylated
form of histone H2AX (gH2AX) in the nucleus by immu-
noﬂuorescence of the protein. gH2AX is recruited to
DSBs in response to DNA damage. gH2AX-positive
cells were deﬁned as cells harboring the discrete large-
sized foci of the protein. The frequency of gH2AX-
positive cells was 4.3% in wild-type cells, whereas it was
increased to 55.7% in the mutant cells (Figure 6G). These
observations indicate that Chk1 accumulates at centro-
somes in response to unrepaired DNA damage caused
by Rad51C dysfunction in the absence of exogenous
insults. In addition, localization of Chk1 at centrosomes
in response to DNA damage induced by ultraviolet
irradiation or hydroxyurea treatment was promoted by
Rad51C dysfunction. Together with our observation
that the Rad51C mutant cells were hypersensitive to HU
(Figure 2C), these results suggest that Rad51C dysfunc-
tion may lead to prolonged replication fork arrest.
Rad51C dysfunction leads to increased aneuploidy
Supernumerary centrosomes are assumed to play a role
in the generation of aneuploidy by inducing aberrant
chromosome segregation. The frequency of aneuploidy,
characterized by one or three chromosomes, was investi-
gated by FISH using two independent chromosome-
speciﬁc centromere probes (Figure 7A). The frequencies
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Nucleic Acids Research, 2009,Vol.37, No. 12 3965of aneuploidy at chromosomes 7 and 17 were 3.3% and
3.4%, respectively, in wild-type cells, whereas they were
increased to 7.4% and 7.6% in the Rad51C mutant cells
(P<0.01, Fisher’s exact test) (Figure 7B). This indicates
that Rad51C, like other Rad51 paralogs, maintains chro-
mosome stability.
DISCUSSION
We have shown here that Rad51C dysfunction
leads to increases in supernumerary centrosomes in an
ATR-Chk1-dependent manner and to aneuploidy in
human cells. This observation indicates that the DNA
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causes chromosome instability by aﬀecting centrosome
integrity.
In contrast to previous studies using CL-V4B cells
(11,12), the present study demonstrated that centrosome
aberrations were induced by Rad51C dysfunction at both
mitosis and interphase in two independent human cell
lines. Since centrosome aberrations in interphase are
likely to be generated at the S and G2 phases, such a dif-
ference may be explained by a mechanism that regulates
centrosome integrity at these phases of the cell cycle.
Given that the DNA damage response is involved in the
maintenance of centrosome integrity, the absence of a pro-
tein involved in the signaling in response to unrepaired
DNA damage may explain the lack of centrosome aberra-
tions in interphase in CL-V4B cells.
A defect in the mismatch repair pathway has been
shown to interfere with the DNA damage response (27).
Since MLH1, a mismatch repair protein, is mutated in
HCT116 cells, some phenotypes observed in the deriva-
tives of this cell line are likely to be aﬀected by a defect
in mismatch repair. However, ATR-dependent centro-
some aberrations in interphase were also observed in
mismatch-proﬁcient HT1080 cells, thus excluding this
possibility.
The present results, together with those of previous
studies (8–10,12), strengthen the role of Rad51 paralogs
in the maintenance of centrosome integrity. However, it is
unlikely that Rad51 paralogs directly regulate centrosome
functions. There is no evidence to suggest that any
member of the Rad51 paralog family localizes to the cen-
trosome (7). We conﬁrmed that Rad51C does not localize
to the centrosome by exogenous expression of the
RAD51C cDNA fused with the green ﬂuorescent protein
in Rad51C mutant cells (data not shown). Since Rad51C
participates in the formation of two protein complexes
consisting of ﬁve members of the Rad51 paralog family,
these complexes are unlikely to localize to the centrosome.
Evidence that the DNA damage response plays a role in
centrosome functions has been accumulating. ATM,
ATR, ATRIP, Chk1 and Chk2 were shown to localize
to the centrosome in HeLa cells (28). Supernumerary cen-
trosomes in human lymphoblastoid cells exposed to ioniz-
ing radiation were cancelled by treatment with 2mM
caﬀeine or by the depletion of Chk1, suggesting that the
ATM/ATR-Chk1 pathway may be involved in promoting
centrosome ampliﬁcation induced by DNA damage (16).
The ATR-Chk1 pathway’s role in regulating centrosome
functions has been proposed from the identiﬁcation of
mutations in pericentrin, a centrosomal protein, in
Seckel syndrome as well as in Majewski osteodysplastic
primordial dwarﬁsm type II (MOPD II) syndrome
(29,30). These rare genetic disorders share dwarﬁsm
and microcephaly. Since ATR mutations are responsible
for Seckel syndrome (31), the ATR-dependent DNA
damage response signaling pathway might be associated
with the pericentrin-dependent pathway. Although the
exact role of ATR in centrosome functions remains to
be elucidated, these results support the present ﬁnding
that ATR is involved in increased supernumerary centro-
somes. It is also noteworthy that caﬀeine treatment in
Rad51C mutant cells did not reduce the frequency of cen-
trosome aberrations to the wild-type levels, suggesting
that an ATR-independent pathway may play a minor
role in promoting centrosome aberrations in the mutant
cells.
Defective homologous recombination causes prolonged
replication fork arrest. Increased centrosome numbers
that arise spontaneously in Rad51C mutant cells are
likely to be attributable to prolonged arrest at replication
forks or at the G2/M boundary. Furthermore, the present
ﬁnding that ATR or Chk1 depletion reduced centrosome
aberrations suggests that prolonged checkpoint arrest may
cause supernumerary centrosomes. The previous ﬁnding
that centrosome ampliﬁcation induced by Rad51 deletion
was caused during the prolonged G2 phase in an ATM-
dependent manner supports this model (13). However,
ATM is unlikely to be involved in the DNA damage
response that increases centrosome numbers in Rad51C
mutant cells. Although the interplay between ATM and
ATR was shown to function in the DNA damage response
(32,33), Rad51C dysfunction appears to activate the ATR-
speciﬁc pathway. The DNA damage response signaling
pathway activated by Rad51C dysfunction may be diﬀer-
ent from the pathway activated by depletion of Rad51.
Rad51C may play a role in the DNA repair process that
does not depend on Rad51. Rad51C or its associated pro-
teins have been proposed to have a resolvase activity for
Holliday junctions, suggesting that Rad51C may be
involved in the late phase of homologous recombination
(34). Thus, discrimination in the choice of the DNA
damage response signal in their mutant cells may reﬂect
functional diﬀerences between Rad51 and Rad51C in DSB
repair through homologous recombination.
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